US pharma tariffs likely to have limited impact on Indian exports
India’s generic pharma industry, which accounts for the bulk of domestic pharma exports to the US, is expected to remain largely insulated from the fresh tariffs announced by US President Donald Trump.
A year after announcing the…
Read More...
Read More...